{"nctId":"NCT01984424","briefTitle":"Goal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin Intolerant Subjects-3","startDateStruct":{"date":"2013-12-10","type":"ACTUAL"},"conditions":["Hyperlipidemia"],"count":511,"armGroups":[{"label":"Part A: Atorvastatin 20 mg => Placebo","type":"OTHER","interventionNames":["Drug: Atorvastatin","Drug: Placebo to Atorvastatin"]},{"label":"Part A: Placebo => Atorvastatin 20 mg","type":"OTHER","interventionNames":["Drug: Atorvastatin","Drug: Placebo to Atorvastatin"]},{"label":"Part B: Ezetimibe","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Ezetimibe","Other: Placebo to Evolocumab"]},{"label":"Part B: Evolocumab","type":"EXPERIMENTAL","interventionNames":["Other: Placebo to Ezetimibe","Drug: Evolocumab"]},{"label":"Part C: Open-label Evolocumab","type":"EXPERIMENTAL","interventionNames":["Drug: Evolocumab"]}],"interventions":[{"name":"Atorvastatin","otherNames":["Lipitor"]},{"name":"Placebo to Atorvastatin","otherNames":[]},{"name":"Placebo to Ezetimibe","otherNames":[]},{"name":"Ezetimibe","otherNames":["Zetia"]},{"name":"Placebo to Evolocumab","otherNames":[]},{"name":"Evolocumab","otherNames":["Repatha"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Male or female ≥ 18 to ≤ 80 years of age\n* Subject not at LDL-C goal\n* History of statin intolerance\n* Lipid lowering therapy has been stable prior to enrolment for at least 4 weeks\n* Fasting triglycerides ≤ 400 mg/dL\n\nExclusion Criteria:\n\n* New York Heart Association (NYHA) III or IV heart failure\n* Uncontrolled cardiac arrhythmia\n* Uncontrolled hypertension\n* Type 1 diabetes\n* Poorly controlled type 2 diabetes\n* Uncontrolled hypothyroidism or hyperthyroidism","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","maximumAge":"80 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Percent Change From Baseline in LDL-C at the Mean of Weeks 22 and 24","description":null,"paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-16.70","spread":"1.91"},{"groupId":"OG001","value":"-54.50","spread":"1.39"}]}]}]},{"type":"PRIMARY","title":"Percent Change From Baseline in LDL-C at Week 24","description":null,"paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-16.69","spread":"2.11"},{"groupId":"OG001","value":"-52.76","spread":"1.52"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in LDL-C at the Mean of Weeks 22 and 24","description":null,"paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-31.0","spread":"3.8"},{"groupId":"OG001","value":"-106.8","spread":"2.7"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in LDL-C at Week 24","description":null,"paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-31.2","spread":"4.0"},{"groupId":"OG001","value":"-102.9","spread":"2.9"}]}]}]},{"type":"SECONDARY","title":"Percentage of Participants Who Achieved a Mean LDL-C at Weeks 22 and 24 of Less Than 70 mg/dL","description":null,"paramType":"NUMBER","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.4","spread":null},{"groupId":"OG001","value":"29.9","spread":null}]}]}]},{"type":"SECONDARY","title":"Percentage of Participants Who Achieved LDL-C at Week 24 of Less Than 70 mg/dL","description":null,"paramType":"NUMBER","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.0","spread":null},{"groupId":"OG001","value":"27.4","spread":null}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in Total Cholesterol at the Mean of Weeks 22 and 24","description":null,"paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-11.43","spread":"1.41"},{"groupId":"OG001","value":"-38.04","spread":"1.03"}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in Total Cholesterol at Week 24","description":null,"paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-11.57","spread":"1.52"},{"groupId":"OG001","value":"-36.64","spread":"1.10"}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in Non-high-density Lipoprotein Cholesterol (Non-HDL-C) at the Mean of Weeks 22 and 24","description":null,"paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-14.38","spread":"1.72"},{"groupId":"OG001","value":"-47.44","spread":"1.25"}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in Non-HDL-C at Week 24","description":null,"paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-14.62","spread":"1.83"},{"groupId":"OG001","value":"-45.72","spread":"1.32"}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in Apolipoprotein B at the Mean of Weeks 22 and 24","description":null,"paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-11.42","spread":"1.82"},{"groupId":"OG001","value":"-45.28","spread":"1.31"}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in Apolipoprotein B at Week 24","description":null,"paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-11.74","spread":"1.94"},{"groupId":"OG001","value":"-43.50","spread":"1.40"}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in Total Cholesterol/HDL-C Ratio at the Mean of Weeks 22 and 24","description":null,"paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-11.48","spread":"1.75"},{"groupId":"OG001","value":"-41.39","spread":"1.27"}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in Total Cholesterol/HDL-C Ratio at Week 24","description":null,"paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-12.84","spread":"1.85"},{"groupId":"OG001","value":"-40.04","spread":"1.33"}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in Apolipoprotein B/Apolipoprotein A1 Ratio at the Mean of Weeks 22 and 24","description":null,"paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-11.86","spread":"1.89"},{"groupId":"OG001","value":"-45.99","spread":"1.36"}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in Apolipoprotein B/Apolipoprotein A1 Ratio at Week 24","description":null,"paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-12.62","spread":"1.97"},{"groupId":"OG001","value":"-44.60","spread":"1.41"}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in Lipoprotein(a) at the Mean of Weeks 22 and 24","description":null,"paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.63","spread":"2.80"},{"groupId":"OG001","value":"-22.71","spread":"2.03"}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in Lipoprotein(a) at Week 24","description":null,"paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.17","spread":"3.05"},{"groupId":"OG001","value":"-21.06","spread":"2.19"}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in Triglycerides at the Mean of Weeks 22 and 24","description":null,"paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.95","spread":"3.94"},{"groupId":"OG001","value":"-5.39","spread":"2.84"}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in Triglycerides at Week 24","description":null,"paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.07","spread":"4.97"},{"groupId":"OG001","value":"-2.88","spread":"3.54"}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in High-density Lipoprotein Cholesterol (HDL-C) at Week 24","description":null,"paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.66","spread":"1.71"},{"groupId":"OG001","value":"7.85","spread":"1.24"}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in HDL-C at Week 24","description":null,"paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2.90","spread":"1.89"},{"groupId":"OG001","value":"7.40","spread":"1.36"}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in Very Low-density Lipoprotein Cholesterol (VLDL-C) at the Mean of Weeks 22 and 24","description":null,"paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-2.15","spread":"3.22"},{"groupId":"OG001","value":"-6.81","spread":"2.33"}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in VLDL-C at Week 24","description":null,"paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-2.66","spread":"3.88"},{"groupId":"OG001","value":"-3.90","spread":"2.78"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":9,"n":145},"commonTop":["Myalgia","Muscle spasms","Fatigue","Headache","Nasopharyngitis"]}}}